More than 17 percent of adults over 60, wittingly or not, abuse prescription drugs.

Now Available - National Prescription Drug Abuse Prevention Strategy 2010

National Prescription Drug Abuse Prevention Strategy 2010

The 2010 National Prescription Drug Abuse Prevention Strategy is a product of consultations with more than 40 experts from various sectors of society. The Strategy has been endorsed by 25 not-for-profit health and safety organizations and professional associations.

"As a Registered Nurse, I fully understand the need for patients to have access to medications, but unfortunately, I know too well the urgency of the need to reduce prescription drug abuse, as I lost my son, Ryan, to prescription drugs. RYAN's Cause is pleased to grant its endorsement of this strategy."

- Francine Haight, Founder of RYAN's Cause (Reaching Youths Abusing Narcotics)

Download the Booklet

Click here to download the National Prescription Drug Abuse Prevention Strategy 2010.

(PDF document, 1.68 MB in size)

To view the document, you will need Adobe Acrobat Reader or another PDF reading program.

Join us on LinkedIn

News

New Medications Pose Tricky PR Test, as FDA Gaffe Shows

July 23, 2010

As pain relievers introducing limits to abuse come to market, the FDA is grappling with the best way to encourage manufacturers to communicate risks vs. benefits and ensure safety.

Families Urge FDA to Clarify Risks in OxyContin Reformulation

July 20, 2010

Bob Pack and April Rovero have become activists to help curb prescription drug abuse. Citizen Petition.

Drugmakers Want Balance Between Safety and Patient Access in Opioid REMS

July 19, 2010

Although drugmakers are welcoming a final version of a classwide opioid risk evaluation and mitigation strategy (REMS), they believe it should protect patient safety without hindering reasonable access to the products.

"Drugmakers Want Balance Between Safety and Patient Access in Opioid REMS", Drug Industry Daily, July 19, 2010. FDAnews, 300 N. Washington St., Suite 200, Falls Church, VA 22046-3431, +1 (703) 538-7600 www.fdanews.com.

California Legislature Debates Step Therapy Ban

July 15, 2010

A bill to ban step therapy is currently under consideration in California’s general assembly. CLAAD support this bill. States should abandon blind cost-saving measures such as step therapy, as the detriments to patient medical care and the public health outweigh the financial benefits. Health care professionals must be able to prescribe medications that are best suited to their patients’ unique medical needs. Full story.

CLAAD Supports Recovery High Schools

Recovery high schools provide a substance-free learning environment to teens with addictive disorders, including prescription drug abuse. CLAAD supports recovery high schools as an effective means of providing abuse and addiction support services to adolescents.